TNF and neoplasm: Using the NF-κB inhibitor DHMEQ, Yamashita and colleagues showed decreased tumor growth, cancer cell invasion, increased apoptosis, as well as TNFα- and taxane-induced apoptosis in a single ATC cell line [13,14].